Avantor (NYSE:AVTR) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Avantor (NYSE:AVTR) posted its quarterly earnings results on Wednesday. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.02, FiscalAI reports. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.61 billion. During the same quarter in the previous year, the business earned $0.24 earnings per share. The company’s revenue was up .5% on a year-over-year basis. Avantor updated its FY 2026 guidance to 0.800-0.830 EPS.

Here are the key takeaways from Avantor’s conference call:

• Q2 results exceeded expectations, with revenue of $1.69 billion, adjusted EPS of $0.21, and $152 million in free cash flow excluding restructuring costs.
• VWR Distribution & Services returned to organic growth, up 1.7% year over year, supported by stronger large-customer execution, improved e-commerce performance, and increased pharma and biotech activity.
• Avantor raised its 2026 organic revenue growth outlook to -0.5% to 0.5% and adjusted EPS guidance to $0.80-$0.83, while expecting BMP to return to growth in the second half.
• Strong cash generation enabled $112 million of debt repayment during the quarter and nearly $500 million over the past 12 months; management remains committed to reducing adjusted net leverage below 3 times by year-end.
• BMP organic revenue declined 5.6% in Q2, while consolidated and segment margins faced lower volumes, inflation, freight costs, and unfavorable product mix; education and European demand also remained weaker than desired.

Avantor Stock Performance

Avantor stock traded down $0.14 during trading on Friday, reaching $13.72. The company had a trading volume of 5,446,571 shares, compared to its average volume of 10,835,298. Avantor has a 52 week low of $7.26 and a 52 week high of $15.93. The firm’s 50-day simple moving average is $10.14 and its 200 day simple moving average is $9.42. The firm has a market capitalization of $9.37 billion, a price-to-earnings ratio of -16.35, a price-to-earnings-growth ratio of 7.88 and a beta of 0.94. The company has a current ratio of 1.78, a quick ratio of 1.17 and a debt-to-equity ratio of 0.65.

Key Avantor News

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Q2 earnings and revenue beat expectations: Avantor reported adjusted EPS of $0.21 versus the $0.19 consensus, while revenue reached $1.69 billion compared with estimates of $1.61 billion. VWR returned to organic growth earlier than expected, providing evidence of improving operating momentum. Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
• Positive Sentiment: Guidance was raised: Management maintained a 2026 adjusted EPS outlook of $0.80-$0.83 and expects adjusted net leverage below 3x, signaling confidence in earnings and balance-sheet improvement. Avantor outlines 2026 adjusted EPS and leverage targets
• Positive Sentiment: Analyst sentiment improved: Wells Fargo raised its price target to $16 from $14 and kept an overweight rating; Stifel increased its target to $15 from $8, and Morgan Stanley raised its target to $14 from $10. Wolfe Research also upgraded Avantor from strong sell to hold.
• Positive Sentiment: Technical momentum strengthened: AVTR’s 50-day moving average moved above its 200-day average, creating a “golden cross,” a signal that can attract momentum-oriented investors. Avantor Just Flashed Golden Cross Signal
• Neutral Sentiment: Jefferies upgraded Avantor from underperform to hold, but its $13 price target remains below the recent trading range. Stifel and Morgan Stanley also retain hold or equal-weight ratings, suggesting some analysts view much of the earnings optimism as already reflected in the stock.
• Negative Sentiment: Broader risk sentiment remains a potential headwind as oil-market volatility, U.S.-Iran tensions and uncertainty ahead of the Federal Reserve’s decision pressured equities. Profit-taking after AVTR’s sharp post-earnings advance could also limit near-term upside. Oil Surge and Nasdaq Market Sell-Off

Insiders Place Their Bets

In related news, Director Gregory T. Lucier purchased 10,000 shares of the business’s stock in a transaction on Friday, May 8th. The stock was acquired at an average price of $8.32 per share, with a total value of $83,200.00. Following the completion of the acquisition, the director owned 60,000 shares of the company’s stock, valued at approximately $499,200. This trade represents a 20.00% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.28% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in AVTR. EverSource Wealth Advisors LLC lifted its position in shares of Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after buying an additional 1,189 shares in the last quarter. Los Angeles Capital Management LLC bought a new stake in Avantor during the 4th quarter worth approximately $32,000. Strategic Wealth Investment Group LLC bought a new stake in Avantor during the 2nd quarter worth approximately $32,000. Osaic Holdings Inc. lifted its holdings in Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Avantor by 28.1% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after purchasing an additional 905 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Barclays raised their price target on Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, June 24th. Wells Fargo & Company upped their price objective on Avantor from $14.00 to $16.00 and gave the company an “overweight” rating in a research report on Thursday. Evercore set a $10.50 target price on Avantor in a research report on Monday, July 6th. Zacks Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 30th. Finally, TD Cowen reaffirmed a “hold” rating on shares of Avantor in a research report on Wednesday, July 15th. Two research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Avantor presently has an average rating of “Hold” and an average target price of $12.00.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.